InvestorsHub Logo
Followers 137
Posts 22776
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Saturday, 07/26/2014 4:18:49 PM

Saturday, July 26, 2014 4:18:49 PM

Post# of 2205
Dr. Geoff Symonds

GEOFF SYMONDS, PhD, Chief Scientific Officer

Dr. Symonds began his career in academic research with an undergraduate and Master's degree from the University of Sydney; he later obtained his Ph.D. from the Weizmann Institute, and conducted his Postdoctoral Fellowship at UCSF with Michael Bishop and Harold Varmus. As an academician, he managed a successful research group at the Children's Medical Research Institute in Sydney from 1985 to 1992. While in this position, Dr. Symonds was awarded two prestigious Senior and Principal Research Fellowships through the Australian National Health and Medical Research Council. In 1992, he joined Johnson & Johnson (J&J) Research in Sydney to lead their HIV and cancer programs and went on to drive their HIV gene therapy R&D program through pre-clinical development to two Phase I and one Phase II clinical trials. He received the esteemed Philip B. Hoffman Research Scientist Award for Outstanding Achievement in the field of Research and Development for this work. Dr. Symonds has been with Calimmune since early 2009 and heads research and development. He has published over 100 research papers and holds several key patents in the area of HIV gene therapy.

http://www.calimmune.com/leadership_team.php

Good luck and GOD bless,

George
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BNTC News